Clinical trials
Phase 3 Sepsis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 6 |
| Completed | 3 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Southeast University, China | 2 |
| Sun Yat-sen University | 2 |
| China Medical University, China | 1 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| First Affiliated Hospital Xi'an Jiaotong University | 1 |
| Huashan Hospital | 1 |
| Hunan Children's Hospital | 1 |
| National Taiwan University Hospital | 1 |
| Qilu Pharmaceutical Co., Ltd. | 1 |
| The Third Xiangya Hospital of Central South University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sepsis | 12 |
| Acute Kidney Injury | 1 |
| Anemia | 1 |
| Bronchopulmonary Dysplasia | 1 |
| Candidemia | 1 |
| Candidiasis | 1 |
| Candidiasis, Invasive | 1 |
| Disseminated Intravascular Coagulation | 1 |
| Fungemia | 1 |
| Gram-Negative Bacterial Infections | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.